Japan
Regenerative medicine product development using stem cells
Manufacturing and sales of regenerative medicine products
Research and development of stem cell therapies
Licensing and commercialization of inducible inhibitory T-cells (JB-101)
Hiroyuki Sonoda
Company name
Group
Parent
Subsidiary
Customer
Supplier
Alliance
Bank
Shareholder
Loading...
Loading the relationship graph...
2026-09-21 18:13 (Model: ggml-org/gpt-oss-20b )